Surfactant for digital PCR (polymerase chain reaction) droplet generation oil as well as preparation method and application of surfactant

By designing surfactants with specific structures, combining perfluoropolyether carboxylic acid and polyether diamine, droplet generation oil with good stability and high temperature resistance are prepared, which solves the instability of existing droplet generation oil at room temperature. The problem of droplet fusion under high temperature circulation meets the needs of single-cell sequencing projects.

CN119019694APending Publication Date: 2024-11-26SUZHOU CANGMUXIN TECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411142018.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-20
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The existing digital PCR droplet generation oil is unstable at room temperature, easily emulsified and white, and it is difficult to meet the high-temperature cycle requirements of single-cell sequencing projects.

Method used

By designing surfactants with specific structures, combining perfluoropolyether carboxylic acid and polyether diamine, controlling the molecular weight of the hydrophobic end and hydrophilic section, a new type of droplet-forming oil has good stability and high temperature resistance.

Benefits of technology

The long-term stability of droplet generation oil at room temperature and the droplet morphological integrity after high temperature circulation are achieved, meeting the needs of single-cell sequencing projects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119019694A_ABST
    Figure CN119019694A_ABST
Patent Text Reader

Abstract

The invention discloses a surfactant for digital PCR liquid drop generation oil and a preparation method and application thereof, the surfactant has the following structural general formula: # imgabs0 #, n is an integer from 10 to 19, x is an integer from 1 to 5, y is an integer from 5 to 15, and z is an integer from 1 to 5. The novel surfactant is prepared by designing the molecular weight of the hydrophobic end of the surfactant and the structure and molecular weight of the hydrophilic section of the surfactant. The surfactant is used for preparing the droplet-generating oil, and the droplet-generating oil with good stability and high temperature resistance can be obtained by controlling the mass percent of the surfactant in the droplet-generating oil, so that the change requirements in a single cell sequencing project are met, and the surfactant has a good application prospect in the aspect of digital PCR.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of digital PCR, and in particular to a surfactant for digital PCR droplet generation oil, and a preparation method and application thereof. Background Art

[0002] The rapid development and application of digital PCR is particularly important in single-cell sequencing technology. Among them, generating single droplets of uniform size and stability through microfluidics technology is the most critical step in single-cell sequencing.

[0003] Fluorinated droplet generation oil as the oil phase has the advantages of excellent chemical stability and good biocompatibility. Currently, single-cell projects mainly rely on Bio-rad droplet generation oil, which can meet the high-temperature cycle of digital PCR, but the droplet generation oil is unstable at room temperature and is easy to emulsify and turn white, which makes it easy to lose the function of surfactant.

[0004] With the continuous optimization and upgrading of single-cell sequencing products, the requirements for droplet generation oil are also constantly changing and improving. Based on this, there is an urgent need for a droplet generation oil with good stability, good high temperature resistance and that can meet the changing requirements in single-cell sequencing projects. Summary of the invention

[0005] To solve the above problems, the present invention provides a surfactant for digital PCR droplet generation oil and its preparation method and application. The present invention designs the structure of the surfactant, an important component of the droplet generation oil, and specifically designs the molecular weight of the hydrophobic end of the surfactant and the structure and molecular weight of the hydrophilic segment to obtain a new surfactant. The droplet generation oil formed by the surfactant and the fluorinated liquid has good stability and high temperature resistance, and can meet the changing needs in single-cell sequencing projects.

[0006] In order to solve the above technical problems, the present invention provides the following technical solutions:

[0007] In a first aspect, the present invention provides a surfactant for digital PCR droplet generation oil, wherein the surfactant has the following general structural formula:

[0008]

[0009] Wherein, n is an integer from 10 to 19;

[0010] x is an integer from 1 to 5;

[0011] y is an integer from 5 to 15;

[0012] z is an integer from 1 to 5.

[0013] The present invention designs the structure of a surfactant, which is an important component of the droplet generation oil, and uses a perfluoropolyether carboxylic acid of a specific molecular weight and a polyether diamine of a specific structure and molecular weight to prepare a novel surfactant, wherein the perfluoropolyether carboxylic acid forms the hydrophobic end of the surfactant, the polyether diamine forms the hydrophilic segment of the surfactant, and the n value of the hydrophobic end needs to be controlled within a suitable range. If the n value is too large, the stability of the droplet generation oil formed by the surfactant is poor. If the n value is too small, the prepared droplet generation oil cannot withstand a high-temperature PCR reaction. Preferably, the n value is controlled within the range of 10-19, for example, n is 10, 11, 12, 13, 14, 15, 16, 17, 18 or 19. In addition, the structure of the hydrophilic segment in the surfactant will also affect the long-term stability and high temperature resistance of the droplet generation oil. Compared with a surfactant containing only a single polyether segment, the surfactant having different polyether segments of the present invention has better stability and high temperature resistance.

[0014] Further, x is 2, y is 9, and z is 2.

[0015] The second aspect of the present invention provides a method for preparing the surfactant according to the first aspect, comprising the following steps:

[0016] The surfactant is obtained by reacting perfluoropolyether carboxylic acid and polyether diamine in the presence of a fluorinated liquid and a catalyst; the catalyst is a fluorine-containing phosphate;

[0017] The structure of the perfluoropolyether carboxylic acid is shown below:

[0018] n is an integer from 10 to 19;

[0019] The structure of the polyether diamine is shown below:

[0020] x is an integer of 1-5, y is an integer of 5-15, and z is an integer of 1-5.

[0021] Furthermore, the molar ratio of the polyether diamine to the perfluoropolyether carboxylic acid is 1:(1-2), for example 1:1, 1:1.1, 1:1.2, 1:1.3, 1:1.4, 1:1.5, 1:1.6, 1:1.7, 1:1.8, 1:1.9 or 1:2, including but not limited to the molar ratios listed above.

[0022] Furthermore, the weight average molecular weight of the perfluoropolyether carboxylic acid is preferably 1800-3000, for example 1800, 1900, 2000, 2100, 2200, 2300, 2400, 2500, 2600, 2700, 2800, 2900 or 3000, including but not limited to the molecular weights listed above; the weight average molecular weight of the polyether diamine is preferably 600-900, for example 600, 700, 750, 800, 850, 900, etc.

[0023] Furthermore, the fluorinated liquid is preferably one or more of HFE7100 (methyl nonafluorobutyl ether), HFE7200 (ethyl nonafluorobutyl ether), HFE7300 (decafluoro-3-methoxy-2-trifluoromethylpentane), HFE7500 (2-(trifluoromethyl)-3-ethoxydodecafluorohexane), FC40 (perfluorotributylamine), and FC3283 (perfluorotripropylamine), which are used to dissolve perfluoropolyether carboxylic acid.

[0024] Furthermore, the fluorine-containing phosphate is preferably one or more of potassium hexafluorophosphate, sodium hexafluorophosphate, and lithium hexafluorophosphate.

[0025] Furthermore, the volume ratio of the perfluoropolyether carboxylic acid to the fluorinated liquid is preferably 1:(1-2), such as 1:1, 1:1.1, 1:1.2, 1:1.3, 1:1.4, 1:1.5, 1:1.6, 1:1.7, 1:1.8, 1:1.9 or 1:2, including but not limited to the volume ratios listed above.

[0026] Furthermore, the volume ratio of the perfluoropolyether carboxylic acid to the catalyst is 1:(2-2.2), for example 1:2, 1:2.02, 1:2.04, 1:2.06, 1:2.08, 1:2.1, 1:2.12, 1:2.14, 1:2.16, 1:2.18 or 1:2.2, including but not limited to the volume ratios listed above.

[0027] Furthermore, the reaction temperature is preferably 30-80°C, for example 30°C, 35°C, 40°C, 45°C, 50°C, 55°C, 60°C, 65°C, 70°C, 75°C or 80°C, and the reaction time is 8-12h, for example 8h, 8.5h, 9h, 9.5h, 10h, 10.5h, 11h, 11.5h or 12h, etc.

[0028] Furthermore, the preparation method also includes adding a fluorine-containing solvent to the system after the reaction to dissolve the product, and then adding a polar solvent to the filtered filtrate to precipitate the solid to obtain the surfactant; preferably, the fluorine-containing solvent is selected from one or more of HFE7100, HFE7200, HFE7300, HFE7500, FC40, and FC3283 fluorinated liquids, and the polar solvent is selected from one or more of ethanol, ethyl acetate, and difluoromethane.

[0029] The third aspect of the present invention provides a droplet generation oil, comprising the surfactant and solvent described in the first aspect, wherein the solvent is selected from one or more of anhydrous HFE7100, HFE7200, HFE7300, HFE7500, FC40, and FC3283 fluorinated liquids to avoid emulsification of the surfactant and water in the solvent; the mass percentage of the surfactant in the droplet generation oil is 2%-6%, for example, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 5.5%, 6%, etc., including but not limited to the mass percentages listed above.

[0030] The fourth aspect of the present invention provides a method for preparing the droplet formation oil described in the third aspect, comprising uniformly mixing the surfactant and the solvent to obtain the droplet formation oil.

[0031] The fifth aspect of the present invention provides an application of the droplet generation oil described in the third aspect in digital PCR single-cell sequencing.

[0032] Compared with the prior art, the present invention has the following beneficial effects:

[0033] The present invention provides a surfactant and droplet generation oil for digital PCR droplet generation oil. A new surfactant is obtained by designing the structure and molecular weight of the hydrophobic end and the hydrophilic segment of the surfactant. The droplet generation oil prepared by mixing the surfactant with a fluorinated liquid has excellent stability and can remain clear and transparent after being placed at room temperature for 9 months. More importantly, the droplets formed by the microfluidic chip using the droplet generation oil after standing for 9 months as the oil phase are placed at room temperature for a long time, and the morphology and size of the droplets before and after the placement are almost unchanged, showing good stability; and after the PCR high temperature cycle test, the morphology of the droplets can still remain intact, the size is uniform, and there is no droplet fusion phenomenon, showing excellent high temperature resistance.

[0034] The droplet generation oil provided by the present invention has good application prospects in digital PCR single-cell sequencing and can meet the changing needs in single-cell sequencing projects. BRIEF DESCRIPTION OF THE DRAWINGS

[0035] Figure 1The hydrogen nuclear magnetic resonance spectrum of the surfactant prepared in Example 1;

[0036] Figure 2 The stability test result diagram of the droplet generation oil provided in Application Example 1;

[0037] Figure 3 A graph showing the stability test results of the droplet generation oil provided in Comparative Application Example 3;

[0038] Figure 4 A microscope photo of the morphology of droplets generated by the droplet generation oil provided in Application Example 1 through a microfluidic chip;

[0039] Figure 5 A microscope photo of the morphology of droplets generated by the droplet generation oil provided in Application Example 1 through the microfluidic chip after being placed for three days;

[0040] Figure 6 A microscope photo of droplets generated by the droplet generation oil provided in Application Example 1 through a microfluidic chip before digital PCR testing;

[0041] Figure 7 This is a microscope photo of droplets generated by the droplet generation oil provided in Application Example 1 through a microfluidic chip after digital PCR testing. DETAILED DESCRIPTION

[0042] The present invention is further described below in conjunction with the accompanying drawings and specific embodiments so that those skilled in the art can better understand the present invention and implement it, but the embodiments are not intended to limit the present invention.

[0043] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art of the present invention. The terms used herein in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention. The term "and / or" used herein includes any and all combinations of one or more related listed items.

[0044] Example 1

[0045] This embodiment relates to the preparation of a surfactant, the structure of which is shown below: Wherein, n=15, x=2, y=9, z=2;

[0046] The preparation process is as follows:

[0047] Perfluoropolyether carboxylic acid ( n=15,2mmol)、polyether diamine ( x=2, y=9, z=2, 1mmol), HFE 7100 solvent (10mL) and potassium hexafluorophosphate (2.1mmol) were mixed, reacted at 50°C for 10h, HFE 7100 solvent (10mL) was added to the reaction system, filtered, ethanol (50mL) was added to the filtrate, solid was precipitated, filtered to obtain a surfactant;

[0048] The surfactant prepared in this preparation example was tested by nuclear magnetic resonance hydrogen spectrum, and its nuclear magnetic hydrogen spectrum is as follows: Figure 1 As shown, the target surfactant was prepared.

[0049] Example 2

[0050] This embodiment relates to the preparation of a surfactant, and the only difference from the embodiment 1 is that the perfluoropolyether carboxylic acid in the embodiment 1 is replaced by a high molecular weight perfluoropolyether carboxylic acid ( n=10), and other conditions are consistent with those in Example 1, to prepare the corresponding surfactant.

[0051] Example 3

[0052] This embodiment relates to the preparation of a surfactant, and the only difference from the embodiment 1 is that the perfluoropolyether carboxylic acid in the embodiment 1 is replaced by a high molecular weight perfluoropolyether carboxylic acid ( n=19), and other conditions were consistent with those in Example 1 to prepare the corresponding surfactant.

[0053] Comparative Example 1

[0054] This comparative example relates to the preparation of a surfactant, and the only difference from Example 1 is that the perfluoropolyether carboxylic acid in Example 1 is replaced by a high molecular weight perfluoropolyether carboxylic acid ( n=20), and other conditions were consistent with those in Example 1 to prepare the corresponding surfactant.

[0055] Comparative Example 2

[0056] This comparative example relates to the preparation of a surfactant, and the only difference from Example 1 is that the perfluoropolyether carboxylic acid in Example 1 is replaced by a low molecular weight perfluoropolyether carboxylic acid ( n=8), and other conditions are consistent with those in Example 1, to prepare the corresponding surfactant.

[0057] Comparative Example 3

[0058] This comparative example relates to the preparation of a surfactant, and the only difference from Example 1 is that the polyether diamine in Example 1 is replaced by polyethylene glycol diamine ( m=13), and other conditions are consistent with those in Example 1 to prepare the corresponding surfactant.

[0059] Application Example 1

[0060] This application example involves the preparation of a droplet generation oil, and the specific operations are as follows:

[0061] The surfactant prepared in Example 1 was mixed evenly with HFE7100 solvent (3M Novec) at a mass ratio of 4:96 to obtain droplet generation oil.

[0062] Application Example 2

[0063] This application example involves the preparation of a droplet generation oil, and the only difference from application example 1 is that the mass percentage of the surfactant in the droplet generation oil is 2%.

[0064] Application Example 3

[0065] This application example involves the preparation of a droplet generation oil, and the only difference from application example 1 is that the mass percentage of the surfactant in the droplet generation oil is 6%.

[0066] Application Example 4

[0067] The surfactant prepared in Example 2 was mixed evenly with HFE7100 solvent (3M Novec) at a mass ratio of 4:96 to obtain droplet generation oil.

[0068] Application Example 5

[0069] The surfactant prepared in Example 3 was uniformly mixed with HFE7100 solvent (3M Novec) at a mass ratio of 4:96 to obtain droplet generation oil.

[0070] Comparative application example 1

[0071] This comparative application example involves the preparation of a droplet generation oil, and the only difference from application example 1 is that the mass percentage of the surfactant in the droplet generation oil is 1%.

[0072] Comparative Application Example 2

[0073] This comparative application example involves the preparation of a droplet generation oil, and the only difference from application example 1 is that the mass percentage of the surfactant in the droplet generation oil is 8%.

[0074] Comparative Application Example 3

[0075] This comparative application example involves the preparation of a droplet generation oil, and the only difference from Application Example 1 is that the surfactant prepared in Comparative Example 1 is used instead of the surfactant prepared in Example 1.

[0076] Comparative Application Example 4

[0077] This comparative application example involves the preparation of a droplet generation oil, and the only difference from Application Example 1 is that the surfactant prepared in Comparative Example 2 is used instead of the surfactant prepared in Example 1.

[0078] Comparative Application Example 5

[0079] This comparative application example involves the preparation of a droplet generation oil, and the only difference from Application Example 1 is that the surfactant prepared in Comparative Example 3 is used instead of the surfactant prepared in Example 1.

[0080] Performance Testing

[0081] The performance of the droplet generation oil prepared in the above application examples and comparative application examples was tested using commercially available droplet generation oil for Probes (Bio-Rad, catalog number 1863005) as a control sample. The specific test method is as follows:

[0082] Stability: The droplet generation oil provided in the above application examples and comparative application examples and the control sample were left to stand at 25°C for 3 months, 6 months and 9 months, and their appearance was observed;

[0083] The droplet generation oil and the control sample provided in the above application examples and comparative application examples were placed for 3 months, 6 months and 9 months respectively before microfluidic droplet generation. In the microfluidic chip, the droplet generation oil was used as the oil phase and the single cells were used as the water phase. Droplets were generated under stable pressure (18KPa) conditions. The formed droplets were observed under a microscope and then placed at room temperature for 3 days. The morphology of the droplets after 3 days was observed again under a microscope to compare the morphology of the droplets before and after 3 days of placement.

[0084] High temperature resistance: Use a microscope to characterize the droplets generated by the droplet generation oil provided in the above application examples and comparative application examples and the control sample through the microfluidic chip in the digital PCR test, and then perform digital PCR tests on the droplets respectively, characterize the droplets after the PCR test, and observe the morphology of the droplets after the digital PCR test;

[0085] Among them, the specific process of digital PCR testing is:

[0086]

[0087] The above test results are shown in Table 1 below:

[0088] Table 1

[0089]

[0090]

[0091]

[0092] Note: When conducting high temperature resistance test, if the PCR test is performed after long-term standing, and the droplet size remains uniform after the test, it means that the droplet generated oil is still within the validity period.

[0093] As shown in Table 1, the droplet generation oil (Application Examples 1-5) prepared by using the surfactants prepared in Examples 1-3 and adding them in a suitable ratio can remain clear and transparent when placed at room temperature for 3-9 months; and the droplets formed by using the droplet generation oil after standing for 9 months as the oil phase have no obvious difference in morphology and size after being placed at room temperature for 3 days compared with before placement (such as Figure 4 , 5 As shown in the figure, it can be seen that the droplet generation oil provided by the present invention and the droplets formed therefrom have excellent long-term stability at room temperature. However, the commercially available droplet generation oil (control sample) will emulsify after being placed at room temperature for 6 months, and the droplets formed by the droplet generation oil placed for more than 6 months are unstable at room temperature and high temperature.

[0094] In addition, the droplet generation oil provided in Application Examples 1-5 was left at room temperature for 9 months before being subjected to a digital PCR test. After high-temperature cycles in the PCR amplification cycle, the droplets formed by the droplet generation oil remained intact and uniform in size, and no droplet fusion was observed, showing excellent high temperature resistance. Taking the droplet generation oil prepared in Application Example 1 for digital PCR testing as an example, the droplet morphology before PCR amplification was observed under a microscope. Figure 6 As shown in Figure 2, after 10 heating cycles, the droplets were taken and observed under a microscope. Figure 7 As shown, the droplet morphology and size are consistent with the droplet morphology before amplification. The droplet generation oil provided by other comparative application examples and control samples was used for digital PCR test after standing for 9 months, and obvious droplet fusion phenomenon was observed after PCR test.

[0095] It can be seen from Application Example 1 and Comparative Application Examples 1 and 2 that too high or too low a content of surfactant in the droplet generating oil will affect the stability of droplets formed by the droplet generating oil at room temperature and high temperature. When the mass percentage of the surfactant in the droplet generating oil is 2%-6%, the droplets formed thereby have better stability and high temperature resistance.

[0096] It can be seen from Application Example 1 and Comparative Application Examples 3 and 4 that if the molecular weight of the hydrophobic end of the surfactant in the droplet forming oil is too high or too low, it will affect the stability of the droplet forming oil and the droplets formed at room temperature and high temperature. Figure 2 , 3 As shown, Figure 2The picture of the droplet generation oil prepared in Application Example 1 after standing at room temperature for 6 months. As shown in the figure, the droplet generation oil is still clear and transparent, while the picture of the droplet generation oil prepared in Application Example 3 after standing at room temperature for 6 months is as shown in the figure. Figure 3 As shown, obvious emulsification and whitening phenomenon occurs. And as shown in Table 1, the droplet generation oil provided by comparative application examples 3 and 4 was subjected to digital PCR test after standing for 9 months. After the PCR test, obvious droplet fusion phenomenon can be observed. It can be seen that controlling the molecular weight of the hydrophobic end of the surfactant in a suitable range can effectively improve the stability of the droplet generation oil and the stability of the formed droplets at room temperature and high temperature.

[0097] It can be seen from Application Example 1 and Comparative Application Example 5 that the structure of the surfactant hydrophilic segment in the droplet generation oil will affect the stability of the formed droplets, among which the droplets formed by the droplet generation oil prepared in Comparative Example 3 (including the surfactant prepared in Comparative Example 3) have poor stability at room temperature and high temperature.

[0098] In summary, the present invention can obtain droplet formation oil with excellent long-term stability and high temperature resistance by designing the structure of the surfactant and controlling the amount of the surfactant added to the droplet formation oil.

[0099] The above-described embodiments are only preferred embodiments for fully illustrating the present invention, and the protection scope of the present invention is not limited thereto. Equivalent substitutions or changes made by those skilled in the art based on the present invention are within the protection scope of the present invention. The protection scope of the present invention shall be subject to the claims.

Claims

1. A surfactant for digital PCR droplet generation oil, characterized in that: The surfactant has the following general structural formula: Wherein, n is an integer from 10 to 19; x is an integer from 1 to 5; y is an integer from 5 to 15; z is an integer from 1 to 5.

2. A method for preparing the surfactant according to claim 1, characterized in that: The following steps are involved: The surfactant is obtained by reacting perfluoropolyether carboxylic acid and polyether diamine in the presence of a fluorinated liquid and a catalyst; the catalyst is a fluorine-containing phosphate; The structure of the perfluoropolyether carboxylic acid is shown below: n is an integer from 10 to 19; The structure of the polyether diamine is shown below: x is an integer of 1-5, y is an integer of 5-15, and z is an integer of 1-5.

3. The preparation method according to claim 2, characterized in that: The molar ratio of the polyether diamine to the perfluoropolyether carboxylic acid is 1:(1-2).

4. The preparation method according to claim 2, characterized in that: The fluorinated liquid is selected from one or more of HFE7100, HFE7200, HFE7300, HFE7500, FC40, and FC3283 fluorinated liquids; The fluorine-containing phosphate is selected from one or more of potassium hexafluorophosphate, sodium hexafluorophosphate, and lithium hexafluorophosphate.

5. The preparation method according to claim 2, characterized in that: The volume ratio of the perfluoropolyether carboxylic acid to the fluorinated liquid is 1:(1-2); And / or, the volume ratio of the perfluoropolyether carboxylic acid to the catalyst is 1:(2-2.2).

6. The preparation method according to claim 2, characterized in that: The reaction temperature is 30-80°C, and the reaction time is 8-12h.

7. The preparation method according to claim 2, characterized in that: The preparation method further comprises adding a fluorine-containing solvent to the system after the reaction to dissolve the product, and then adding a polar solvent to the filtered filtrate to precipitate a solid to obtain the surfactant; The fluorine-containing solvent is selected from one or more of HFE7100, HFE7200, HFE7300, HFE7500, FC40, and FC3283 fluorinated liquids, and the polar solvent is selected from one or more of ethanol, ethyl acetate, and difluoromethane.

8. A droplet-generating oil, characterized in that: It comprises the surfactant and solvent according to claim 1, wherein the solvent is selected from one or more of anhydrous HFE7100, HFE7200, HFE7300, HFE7500, FC40, and FC3283 fluorinated liquids; the mass percentage of the surfactant in the droplet forming oil is 2%-6%.

9. A method for preparing the droplet generation oil according to claim 8, characterized in that: The surfactant and the solvent are mixed uniformly to obtain the droplet generation oil.

10. Use of the droplet generation oil according to claim 8 in digital PCR single-cell sequencing.